Dispensing is the count
What goes out comes off the held quantity as it is handed over. There is no separate updating step to fall behind on, which is the only reason a stock figure stays true.
Loading…
When the medicine is dispensed at your own counter, stock stops being a back-office job and becomes part of the consultation.
Ayurvedic and homeopathic practices usually dispense what they prescribe. That changes where the software has to be good: the pharmacy is not a separate business downstairs, it is the last two minutes of the consultation, and the stock figure has to be right at that moment rather than at the end of the month.
It also changes what a prescription is. The formulary is the practice's own — preparations, potencies, combinations that no national drug database will offer you first.
What goes out comes off the held quantity as it is handed over. There is no separate updating step to fall behind on, which is the only reason a stock figure stays true.
Prescribing pulls from the medicines the practice actually keeps and uses. The preparations you reach for most should be the ones offered first.
Items approaching their date are flagged early enough to be used or returned, rather than found at the back of a cupboard six months late.
The fee and what was dispensed appear on the same invoice, with the payment recorded against it — so the counter total and the cash box agree.
Better to know now than in week two. If one of these is central to how you practise, Nabz is probably not the right fit.
Yes — the list is entirely the clinic's own. Nabz does not ship a formulary, which means nothing is missing and nothing irrelevant is in the way.
Stock with low-stock alerts is on the Clinic plan and above. For a practice that dispenses, that is the plan worth starting on.
Yes. Stock received is recorded against the supplier with its batch and expiry, so what came in and what went out are two halves of one ledger.
14 days free, no card needed. If it does not fit your practice you will know inside a week.
Start free trial